COMPANY PROFILE

  

NANOGEN BIOPHARMACEUTICAL  is a leading company that is doing  research and development of active Biopharmaceutical ingredients (APIs), and specific therapeutic injections in Asia Pacific region, based on advance in recombinant DNA and protein technologies.

Nanogen offers a variety of gene-to-therapy biopharmaceuticals for the treatment of hepatitis B, hepatitis C, anemia due to chronic renal failure, oncology, etc.

Our departments and facilities are integrated in the area of 15 000 square meters, located in Saigon Hi-tech Park Ho chi Minh City Vietnam. We research, develop, manufacture and market a wide range of therapeutic injection products under the strict compliance with current GMP and tight QC/QA procedures.

Nanogen’s team consists of high-qualified scientists and graduates in diversity of biotechnology, pharmaceutical and healthcare. We have an international business network with the aim to produce high quality, affordable biotherapeutics.


QUALITY AND CERTIFICATES

Our pharmaceutical facilities are constructed and  operated under strict WHO-GMP quality standard to ensure  that our products’ quality satisfy requirements of WHO-GMP pharmaceutical production.

 

   

MISSION, VISION AND CORE VALUES

Mission: Technology and R&D play a vital role in everything we do.  Our  main goal is to research and produce safe, efficient, and affordable biotherapeutic products.   We’ve been  using advanced technologies to improve the drug formulations for better  tolerability and safety.

Vision: Nanogen’s vision is to manufacture innovative, high-tech biotherapeutics, which will satisfy customers’ demands.  Our long-term goal is to become the leading biopharmaceutical manufacturer in the World and the developer of novel biotherapeutic products

Core Values:

Our values distinguish us, guiding us to have respect for each other for a long term relationship.”

Innovation
Our research is guided by a commitment to preserve human welfare and improve patient compliance.
We understand the challenges of satisfying demands of patients, suppliers and customers. Therefore, we always strive to not only improve ourselves but also   pursue innovation to meet those demands.
Innovative science is the foundation of our main goals.
 

Passion for performance
Our patients deserve our best. We are passionate about what we do and strive for continuous improvement in our performance.

Care
 We care about patients, customers and people.
 We fulfill responsibilities for local communities

Team work

We create a mutual environment for not only inspiring individual creativity, diversity and expertise but also fostering teamwork of our staff.

 We value the commitments and contributions of our employees and their families.

WELCOME YOU TO JOIN US

We welcome you to join us if you are

-A research scientist seeking innovative challenges.

-A biotech or pharmaceutical firm in search of  a prospective partner for your products.

-A business professional interested in exploring solutions for your company’s products.

-Or a supplier with materials, goods or services that  potentially and mutually profit  our companies.

Nanogen treasures partnerships. We are committed to provide high quality of healthcare products, protect the environment, and fulfill responsibilities to local communities.

Everyday we work intimately with scientists, technology experts, medical advisors, business partners, and industry players to develop and market new products.

If necessary, Nanogen is willing to perform Technology Transfer to countries, which have limited resources to manufacture our current medicines.

INTERNATIONAL COOPERATION

Nanogen, a leading pharmaceutical company in research and manufacture in Asia pacific region, is the reliable and stable source of supplying high-quality products with affordable prices for treatment of serious diseases. Until now, we are proceeding on cooperation with several territories all over the world, specially, Asia, South America and Africa, in both dossier registration and technical transfer.

No

Market

Distributor

Products

Dossier status

1

MYANMAR

THET PAING SOE CO., LTD

Sign business agreement

Nanokine 2000 IU (PFS, V, P)

Nanokine 4000 IU (PFS, V, P)

Feronsure 3 MIU (PFS, V, P)

Pegnano 180mcg (PFS)

Ficocyte 30 MU (PFS, V, P)

Nanercept 25/50mg  (PFS, P)          

Waiting for VISA No.

2

PAKISTAN

MARTIN DOW PHARMACEUTICALS LTD.
Sign business agreement

Feronsure 3 MIU (PFS, vial)

Pegnano 180mcg (PFS)

Submitted

Ficocyte 30 MU (PFS, vial)

Nanokine 2000/4000/10000 IU (PFS, V + P)

Being planned

3

TANZANIA

ATLAS PHARMACY LIMITED

Sign business agreement

PEGNANO 180 mcg PFS,

Submitted

FERONSURE 3MIU PFS, NANOKINE 4000 IU PFS,

FICOCYTE 30MU PFS

On process

4

MOROCCO

LES LABORATOIRES SOTHEMA 

Sign business agreement

PEGNANO 180 mcg PFS

Technical transfer

5

UZBEKISTAN

ORVILLE SERVICES LLP

Sign business agreement

PEGNANO

FERONSURE

FICOCYTE

On process

6

SOUTH AFRICA, SWAZILAND, ZIMBAWE, NAMIBIA, ZAMBIA

AVAKASH INTERNATIONAL GROUP HOLDINGS

Sign business agreement

FERONSURE;

On process

PEGNANO; FICOCYTE

NANOKINE

Being planned

7

MOLDOVA

M. BCS-HN S.R.L.

Sign business agreement

PEGNANO

On process

FICOCYTE

NANOKINE

FERONSURE

Being planned

8

NIGERIA

FAMZY NIGERIA LTD.

Sign business agreement

FICOCYTE, PEGNANO, NANOKINE, FERONSURE   

On process

9

VENEZUELA

REPRESENTACIONES BENARES, C.A.

SIGNED CDA

PEGNANO

On process

10<

DOWNLOAD COMPANY'S MATERIALS

Hi-Tech Park considered good...

National Assembly Vice Chairwoman Nguyen Thi Kim Ngan said in her tour to the Hi-Tech Park in Ho...

CPhI Worldwide 2013 – Frankfurt,...

Well-known as an international interactive company in the biopharmaceutical market, Nanogen Biopharmaceutical...